PMV Pharma and Chiromics Announce Licensing Agreement and Drug Discovery Collaboration

Accelerates Discovery and Development of Novel Cancer and Infectious Disease Therapeutics

DOYLESTOWN, PA and PRINCETON, NJ – February 25 , 2014 – PMV Pharmaceuticals, Inc., and Chiromics LLC today announced that they have entered into a collaboration whereby PMV Pharma has a non-exclusive license for use of Chiromics’ chemical compound library and a screening collaboration to discover and optimize novel small molecules against multiple PMV oncology and infectious disease therapeutic targets.